$175.90
0.38% yesterday
NYSE, May 08, 10:00 pm CET
ISIN
US74834L1008
Symbol
DGX

Quest Diagnostics Stock price

$175.90
+16.10 10.08% 1M
+16.53 10.37% 6M
+25.04 16.60% YTD
+39.76 29.21% 1Y
+39.69 29.14% 3Y
+63.68 56.75% 5Y
+104.88 147.68% 10Y
NYSE, Closing price Thu, May 08 2025
-0.67 0.38%
ISIN
US74834L1008
Symbol
DGX
Sector

Key metrics

Market capitalization $19.64b
Enterprise Value $26.13b
P/E (TTM) P/E ratio 22.23
EV/FCF (TTM) EV/FCF 24.75
EV/Sales (TTM) EV/Sales 2.57
P/S ratio (TTM) P/S ratio 1.93
P/B ratio (TTM) P/B ratio 2.84
Dividend yield 1.71%
Last dividend (FY24) $3.00
Revenue growth (TTM) Revenue growth 9.38%
Revenue (TTM) Revenue $10.16b
EBIT (operating result TTM) EBIT $1.46b
Free Cash Flow (TTM) Free Cash Flow $1.06b
Cash position $188.00m
EPS (TTM) EPS $7.91
P/E forward 20.26
P/S forward 1.82
EV/Sales forward 2.42
Short interest 3.58%
Show more

Is Quest Diagnostics a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,791 stocks worldwide.

Quest Diagnostics Stock Analysis

Unlock Scores for Free

Analyst Opinions

22 Analysts have issued a Quest Diagnostics forecast:

10x Buy
45%
11x Hold
50%
1x Sell
5%

Analyst Opinions

22 Analysts have issued a Quest Diagnostics forecast:

Buy
45%
Hold
50%
Sell
5%

Financial data from Quest Diagnostics

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
10,158 10,158
9% 9%
100%
- Direct Costs 6,937 6,937
10% 10%
68%
3,221 3,221
9% 9%
32%
- Selling and Administrative Expenses 1,243 1,243
6% 6%
12%
- Research and Development Expense - -
-
-
1,978 1,978
10% 10%
19%
- Depreciation and Amortization 517 517
15% 15%
5%
EBIT (Operating Income) EBIT 1,461 1,461
9% 9%
14%
Net Profit 892 892
6% 6%
9%

In millions USD.

Don't miss a Thing! We will send you all news about Quest Diagnostics directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Quest Diagnostics Stock News

Positive
Seeking Alpha
6 days ago
Quest Diagnostics excels in scale, scope, and service quality, leveraging automation and distribution to reduce costs and offer comprehensive test menus. Despite its strengths, I recommend waiting to buy DGX at $140 for a 15% IRR, as the current valuation is high. Valuation analysis shows DGX trading at a premium; base case IRR is 8.46%, below my 15% threshold, warranting a Hold rating.
Neutral
Seeking Alpha
17 days ago
Quest Diagnostics Incorporated (NYSE:DGX ) Q1 2025 Results Conference Call April 22, 2025 8:30 AM ET Company Participants Shawn Bevec - Vice President of Investor Relations Jim Davis - Chairman, Chief Executive Officer, President Sam Samad - Chief Financial Officer Conference Call Participants Luke Sergott - Barclays Kevin Caliendo - UBS Patrick Donnelly - Citi Elizabeth Anderson - Evercore ISI...
Positive
Reuters
17 days ago
Laboratory operator Quest Diagnostics beat Wall Street estimates for first-quarter profit on Tuesday, helped by robust demand for its diagnostic tests.
More Quest Diagnostics News

Company Profile

Quest Diagnostics, Inc. engages in the provision fo diagnostic testing, information and services. It operates through the Diagnostic Information Services (DIS) and All Other segments. The DIS segment offers diagnostic information services to patients, clinicians, hospitals, health plans, and employers. The All Other segment consists of risk assessment services, healthcare information technology, diagnostic products, and clinical trials testing businesses. The company was founded in 1967 and is headquartered in Secaucus, NJ.

Head office United States
CEO James Davis
Employees 56,000
Founded 1967
Website www.questdiagnostics.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today